BlueMount Capital Appointed as Corporate Advisor by Ozland Group Solutions
BlueMount Capital is pleased to advise that we have been appointed as Ozland Group Solution’s Corporate Advisor, assisting with executing their exciting growth and acquisition strategies. Continue reading
BlueMount Capital in the news: “Bangladesh: Could corporate Sukuk take off?” IFN 17th March 2021
“Bangladesh turns 50 this month, and in a fitting celebration, March 2021 also saw the country’s first corporate Sukuk announced: a US$250 million issuance from Deshbandhu Group (DGL) expected to mature in 2028. Following on from the government’s first debut sovereign Sukuk back in December 2020, the move is an encouraging one as the economy gathers steam. But with significant barriers remaining to a conducive issuing environment, can Bangladesh maintain its momentum? LAUREN MCAUGHTRY speaks to the lead arranger of the deal to learn more. Continue reading
Initial Public Offering (IPO) on the Australian Securities Exchange (ASX) Q&A Sheet
1. Are US companies welcome to list on the ASX?
ASX welcomes foreign companies including US companies to list. There are around 45 plus US companies listed on the ASX to date, with a pipeline of more companies especially in the technology space to come here every year.
2. What are the main requirements for listing on the ASX?
The Secret to a Successful IPO
There are many measures of success for initial public offerings (IPOs). First and foremost is completing the deal and raising the intended proceeds. From the perspective of remaining and new shareholders, however, the subsequent short-term trading performance is more often seen as the measure of a good IPO as opposed to a bad one.
For the board and management of the newly listed entity, their measure of success and their reputation will depend on how well the newly listed entity performs in the medium term and delivers on the investment proposition on which new shareholders based their investment decision. Continue reading
Capital Market Partners to Lead New USD250m Sukuk, First Bangladesh Corporate Sukuk In International Markets
BlueMount Capital (WA) Pty Ltd (“BlueMount”) and Bedford Row Capital PLC (“BRC”) will act as International Lead Manager and Structuring Agent respectively for a new US$250m Sukuk offering to be listed on the Frankfurt Stock Exchange.
BRC, a global non-bank structuring specialist, has been mandated by Al Waseelah PLC (“Issuer”) whilst BlueMount was appointed by Deshbandhu Group Limited (“DGL”) to lead the first Bangladeshi Corporate Sukuk to help DGL in their next growth phase. The Sukuk will finance the repayment of current outstanding debt and to invest in new technology and scaling up capacity of its group businesses. Continue reading
Fyi Resources Limited (Fyi) Receives First Funds (AU$3.13m) From AU$80m International Fund Arranged By Bluemount Capital (WA)
Key Points
- International fund takes initial stake in FYI with $3.13m opening investment.
- BlueMount Capital (WA) arranged $80m facility for FYI.
- Strategic investment directed at progressing development of FYI High Purity Alumina
(HPA) project. - Placement provides long term major shareholder support.
BlueMount Capital is pleased to announce FYI will receive the first investment from the $80m equity facility it arranged for FYI, with an initial placement of $3.13m. FYI is listed on the Australian Securities Exchange (ASX code: FYI).
The placement of $3.13m is via an issue of 9.3 million shares at a price of 33.67 cents each calculated according to the terms of the capital commitment facility, under FYI’s current ASX Listing Rule 7.1A placement capacity to raise gross proceeds of $3,131,310. Continue reading
Altech – Listed Green Bond Preparations Progressing Well
Highlights
- Listed green bond targeting an offer of ~US$144m
- Preparation progressing well and on track
- HPA project 49% less carbon footprint than conventional HPA
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) (FRA: A3Y) is pleased to advise that preparations for its proposed listed green bond offering of ~US$144 million, to provide additional financing for its Malaysian high purity alumina (HPA) project are on track and progressing well. Continue reading
Technology and International Stock Exchange Listings for US companies
An IPO is often the most important capital markets and wealth creation event in a corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.
Companies consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. Continue reading
Healthcare and International Stock Exchange Listings for US companies
An IPO is often the most important capital markets and wealth creation event in your corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.
Your company should consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. (A fuller discussion of the pros and cons of listing on the Australian Securities Exchange (ASX) versus the Nasdaq or NYSE can be found in the second of this series of BlueMount Capital’s articles: “International Stock Exchange Listings for US Companies”.) Continue reading
International Stock Exchange Listing – Alternatives for US companies
In the past five years there has been a marked increase in the number of international companies listing on the Australian Securities Exchange (ASX). Why is this happening? What are the thought processes and market dynamics that attracted these companies to list on the ASX? Where these companies are U.S. based, what were the factors that stimulated them to look outside their home capital markets? Are the experiences of these companies relevant to your own capital raising considerations? Continue reading